Literature DB >> 35300084

2-Oxooxazolidine-5-carboxamides as Nav1.8 Inhibitors for Treating Pain Disorders, Cough Disorders, and Acute and Chronic Itch Disorders.

Ram W Sabnis1.   

Abstract

Entities:  

Year:  2022        PMID： 35300084      PMCID： PMC8919277          DOI： 10.1021/acsmedchemlett.2c00058

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  6 in total

Review 1.  Mini-review - Sodium channels and beyond in peripheral nerve disease: Modulation by cytokines and their effector protein kinases.

Authors:  Xiaoyang Cheng; Jin-Sung Choi; Stephen G Waxman; Sulayman D Dib-Hajj
Journal:  Neurosci Lett       Date:  2020-11-06       Impact factor: 3.046

Review 2.  Pain behavior in SCN9A (Nav1.7) and SCN10A (Nav1.8) mutant rodent models.

Authors:  Yaping Xue; Celeste Chidiac; Yann Herault; Claire Gaveriaux-Ruff
Journal:  Neurosci Lett       Date:  2021-03-26       Impact factor: 3.046

3.  Novel Approaches, Drug Candidates, and Targets in Pain Drug Discovery.

Authors:  Samuel Obeng; Takato Hiranita; Francisco León; Lance R McMahon; Christopher R McCurdy
Journal:  J Med Chem       Date:  2021-05-06       Impact factor: 7.446

Review 4.  Painful diabetic peripheral neuropathy: Role of oxidative stress and central sensitisation.

Authors:  Di Ye; Timothy J Fairchild; Lechi Vo; Peter D Drummond
Journal:  Diabet Med       Date:  2021-10-28       Impact factor: 4.359

Review 5.  Epigenetic Mechanisms of Neural Plasticity in Chronic Neuropathic Pain.

Authors:  Krishna Ghosh; Hui-Lin Pan
Journal:  ACS Chem Neurosci       Date:  2022-02-02       Impact factor: 4.418

Review 6.  Ventricular voltage-gated ion channels: Detection, characteristics, mechanisms, and drug safety evaluation.

Authors:  Lulan Chen; Yue He; Xiangdong Wang; Junbo Ge; Hua Li
Journal:  Clin Transl Med       Date:  2021-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.